Comparative Pharmacology
Head-to-head clinical analysis: HIBISTAT versus POVIDONE IODINE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: HIBISTAT versus POVIDONE IODINE.
HIBISTAT vs POVIDONE IODINE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), leading to cell lysis and death. Active against susceptible gram-positive bacteria.
Povidone-iodine is an iodophor that releases free iodine upon contact with skin or mucous membranes. Free iodine penetrates microbial cell walls and oxidizes essential cellular components, including proteins, nucleotides, and fatty acids, leading to rapid microbial death. It exhibits bactericidal, fungicidal, and virucidal activity.
1.5 mg/kg intravenously every 6 hours; maximum 120 mg per dose.
Povidone-iodine is a topical antiseptic; no systemic dosing. For skin preparation: apply 10% solution to intact skin and allow to dry for 1-2 minutes. For surgical hand scrub: 7.5% or 10% solution, scrub for 5 minutes. For oral rinse: 1% solution, 10 mL swish for 30 seconds, repeat every 4 hours as needed.
None Documented
None Documented
Terminal elimination half-life is 2.5–3.5 hours in patients with normal renal function; prolonged in renal impairment, requiring dose adjustment.
Iodide half-life approximately 2 days (48 hours); clinical context: prolonged in renal impairment, leading to accumulation.
Approximately 90% of absorbed dose excreted renally as unchanged drug; <5% in feces via biliary elimination.
Renal elimination of iodide; free iodine (I2) is rapidly converted to iodide in blood; ~90% of absorbed iodide excreted renally; remainder in feces, sweat, and saliva.
Category C
Category C
Antiseptic
Antiseptic